Sharon Chinthrajah
Stanford University · Stanford University, Sean N. Parker Center for Allergy and Asthma Research · Stanford, Sean N Parker Center for Allergy and Asthma Center at Stanford
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sharon Chinthrajah as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:25 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07321522 · Early Introduction and Sustained Ingestion (EISI) Using Two Educational Opportunities in InfantsStanford University · recruiting · Food Allergy · principal investigator
- N/ANCT05682625 · Understanding COVID-19 Vaccine Immunity in Tissue and BloodStanford University · withdrawn · COVID-19 (Coronavirus Disease 2019) · principal investigator
- Early Ph1NCT04943744 · Gastrointestinal STRING Test With Oral ImmunotherapyStanford University · terminated · Eosinophilic Disorder, Food Allergy · principal investigator
- N/ANCT04828603 · Understanding Allergies and Sensitizations in Healthy and Allergic IndividualsStanford University · recruiting · Allergy · principal investigator
- N/ANCT04739943 · Remote Monitoring of Respiratory HealthStanford University · terminated · Chronic Respiratory Disease, Asthma, Copd · principal investigator
- N/ANCT04549142 · Immune Tolerance Dysfunction in Pregnancy Due to Ambient Air Pollution ExposureStanford University · completed · Air Pollution, Pregnancy · principal investigator
- Ph3NCT03881696 · Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic ParticipantsNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Peanut Allergy, Multi-food Allergy · study chair
- N/ANCT03539705 · Food Allergy Registry at a Single SiteStanford University · recruiting · Allergy and Asthma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Human Immune Monitoring CoreU19AI167903 · NIAID · STANFORD UNIVERSITY · PI Holden T. Maecker · fiscal years 2022 to 2026Named on NCT05682625
- Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nutsR01AI165866 · NIAID · UNIVERSITY OF COLORADO DENVER · PI STEPHEN C DRESKIN · fiscal years 2021 to 2026Named on NCT04828603
- A single cell pooling framework for deciphering the regulatory wiring of allergy in pathophysiologic contextsDP2HG012480 · NHGRI · STANFORD UNIVERSITY · PI maya kasowski · fiscal years 2021 to 2024Named on NCT04828603
- Immune Tolerance Dysfunction in Pregnancy due to Ambient Air Pollution ExposureR01ES032253 · NIEHS · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Kari C. Nadeau · fiscal years 2020 to 2024Named on NCT04549142
- Evaluating the role of allergen dose and duration in the safety and efficacy of multi-allergen oral immunotherapy with OmalizumabUM1AI130839 · NIAID · STANFORD UNIVERSITY · PI R. Sharon Chinthrajah · fiscal years 2017 to 2023Named on NCT03539705
- Therapeutic and Mechanistic Insights in Food AllergyU01AI182039 · NIAID · STANFORD UNIVERSITY · PI R. Sharon Chinthrajah, SAYANTANI B. SINDHER · fiscal years 2024 to 2026Named on NCT03539705
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:25 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- AR101 Oral Immunotherapy for Peanut Allergy.N Engl J Med · 2018619 citationsRCR 29.7
- 292 citationsRCR 26.0
- 168 citationsRCR 7.5
- Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.J Allergy Clin Immunol · 202075 citationsRCR 4.3
- Transcriptional changes in peanut-specific CD4+ T cells over the course of oral immunotherapy.Clin Immunol · 202033 citationsRCR 1.3
- An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial.Allergy Asthma Proc · 20207 citationsRCR 0.4